Queen RX Review

Queen RX: a bare-bones, bargain-priced quarterly GLP-1 plan

Queen RX is built around one idea: get compounded GLP-1 medication into your hands for as little money as possible. At roughly $100 a month it lands among the cheapest options we track, well under the category median of $169. If your only goal is the lowest sticker price and you're comfortable with a no-frills, lightly documented operation, it's worth a look. If you want a named pharmacy, accreditation badges, or a recognizable corporate entity behind your prescription, this isn't the provider for you.

How the quarterly pricing actually works

Most telehealth GLP-1 providers bill you every month, sometimes with a teaser first month and a higher ongoing rate. Queen RX does it differently: you pay one quarterly charge for three months of medication, which works out to about $100 per month. There's no first-month promo to lure you in and no recurring subscription — the company is explicit that this is a one-time purchase with no membership or hidden monthly fees. That structure is genuinely simpler than the drip-pricing you see elsewhere, but it also means you're paying for a full quarter up front rather than testing the waters one month at a time.

The single charge bundles in the things you'd otherwise pay for separately: a virtual doctor consultation, the prescription if you're approved, three months of medication, and the injection supplies (syringes and alcohol pads). Queen RX does not bill insurance at all, so the cash price is the whole story — there's no copay math to do.

What you get if you're not prescribed

One detail that stands out in Queen RX's own checkout language: if the doctor reviews your intake and decides the medication isn't appropriate for you, you get a full refund. That's a reasonable consumer protection on a prepaid quarterly plan, and it's worth knowing before you hand over a lump sum. Medication ships via UPS from the pharmacy with overnight delivery promised, though note that shipping is described as fast rather than explicitly free.

The medications: three injectables, all compounded

Queen RX offers three GLP-1 options — compounded semaglutide, tirzepatide, and liraglutide. Having all three on one menu is unusual; many budget providers stock only semaglutide. Tirzepatide in particular tends to command a premium elsewhere, so seeing it inside this price band is notable.

The important caveat is the word compounded. These are not the brand-name pens (Wegovy, Zepbound, Ozempic, Saxenda) made by the original manufacturers — they're versions mixed by a compounding pharmacy. Compounded GLP-1s are typically far cheaper, which is how Queen RX hits its price, but they aren't FDA-reviewed the way the branded products are, and quality hinges entirely on the pharmacy doing the mixing.

Where the transparency runs thin

This is where we have to be honest. Queen RX says it works with 'state-licensed U.S. pharmacies,' but it doesn't name a single one. There's no LegitScript certification and no PCAB-accredited compounding partner on file — the two credentials we look for to confirm a pharmacy is operating to recognized standards. The company also doesn't disclose a legal entity name or a physical address; the footer still reads as a 2025 copyright and a single first name, 'Jayla,' appears as a co-founder. Your only listed point of contact is a support email.

• No accreditation: neither LegitScript nor PCAB credentials are shown
• No named pharmacy: medications come from unnamed 'state-licensed U.S. pharmacies'
• No corporate identity: no legal entity name or business address is published
• Limited contact: support is via email only

None of this proves anything is wrong — Queen RX states its affiliated medical practices are independently owned and operated by licensed physicians, which is the standard telehealth structure. But the lack of verifiable detail means you're taking more on faith here than with providers that put their pharmacy and accreditation in writing. For how we weigh these signals, see our scoring methodology.

State availability

Queen RX covers 45 states. It is not available in Kansas, Louisiana, Mississippi, New Mexico, or West Virginia. If you live in one of those five, you'll need to look elsewhere; everywhere else, the quarterly plan is on the table.

Who should choose Queen RX — and who shouldn't

Choose it if you're price-driven above all else, you want access to tirzepatide or liraglutide without paying a premium, and you're comfortable prepaying a quarter for a compounded product from a provider that keeps its operational details sparse. The full-refund-if-not-prescribed policy lowers the downside of trying.

Skip it if accreditation and pharmacy transparency matter to you, if you'd rather pay month to month so you can bail after a few weeks, if you want brand-name medication, or if you live in one of the five excluded states. Patients who value a paper trail — a named pharmacy, a verifiable company, third-party certifications — will sleep better with a more transparent competitor, even at a higher price.

Bottom line

Queen RX delivers exactly what it advertises: rock-bottom compounded GLP-1 pricing, three drug choices, broad state coverage, and a clean no-subscription quarterly bill, softened by a full refund if you aren't approved. The trade-off is transparency. Without a named pharmacy, an accreditation, or a disclosed corporate entity, it asks for more trust than its better-documented rivals. For the budget-first patient who understands those gaps, it's a defensible pick. For anyone who wants reassurance about who is making and shipping their medication, the savings may not be worth the unknowns.

Worth pricing against bmiMD ($99/month) and Brightmeds ($100/month) before you commit — both sit close to Queen RX on cost and formulation.